Covered recipient · General Payments record
TAMER FATHY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018
$140.15
- Reported across 9 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $140.15 | 9 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $56.78 | 3 |
| PFIZER INC. | $29.50 | 2 |
| Merck Sharp & Dohme Corporation | $22.03 | 2 |
| Novo Nordisk AS | $16.84 | 1 |
| GlaxoSmithKline, LLC. | $15.00 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $140.15 | 9 |
Payment records · PY2018 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.28 | 07/06/2018 | Food and Beverage | Undisputed | 01/23/2026 | 578642494 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.25 | 09/07/2018 | Food and Beverage | Undisputed | 01/23/2026 | 578642492 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.25 | 11/16/2018 | Food and Beverage | Undisputed | 01/23/2026 | 578642490 | CMS |
| GlaxoSmithKline, LLC. | $15.00 | 04/27/2018 | Food and Beverage | Undisputed | 01/23/2026 | 594330752 | CMS |
| Merck Sharp & Dohme Corporation | $11.06 | 01/18/2018 | Food and Beverage | Undisputed | 01/23/2026 | 604196281 | CMS |
| Merck Sharp & Dohme Corporation | $10.97 | 10/05/2018 | Food and Beverage | Undisputed | 01/23/2026 | 604665331 | CMS |
| Novo Nordisk Inc | $16.84 | 01/26/2018 | Food and Beverage | Undisputed | 01/23/2026 | 603433587 | CMS |
| PFIZER INC. | $15.03 | 06/01/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610004865 | CMS |
| PFIZER INC. | $14.47 | 12/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | 610225657 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.